EXL to Acquire Vitable Presentation
Filed with ASX · · 10 pages · English
Summary by 6ix AI
Elixinol Wellness Ltd has filed a binding term sheet for the proposed acquisition of Vitable, aimed at enhancing its wellness offerings. The acquisition is expected to unlock strategic value and create synergies across both brands, enhancing customer engagement and revenue opportunities. Vitable's personalized supplement platform will allow Elixinol to build a larger consumer health company with a direct customer relationship. The deal includes deferred consideration with specific conditions and a defined approval path for completion.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Earlier from Elixinol Wellness
- EXL Completion of Divestment of United States Business
- EXL Announce Transformational H1 Results
- EXL Investor Presentation
- The Healthy Chef expands into Priceline
- Repositioned for Sustainable Growth and Margin Expansion
Later from Elixinol Wellness
All Elixinol Wellness news releasesFollow Elixinol Wellness into a list and get an email when it puts out news.
Follow Elixinol Wellness